Sale!

The Ketamine Conference: A Molecular Masterclass

$30.00 $25.00

Ketamine is creating new pathways to pain management and better mental health. We present a complete exploration of ketamine at the intersection of clinical care, research and investment, featuring the world’s top researchers, clinicians, companies, advocates and experts.

Discover the potential of ketamine and NMDA receptor antagonists in the treatment of key mental and physical conditions through keynote presentations, expert panels, interactive discussions and collaboration. This two-day conference brings together experts in the field to discuss the very latest science, health care innovation and business opportunities in this rapidly growing field.


Thank You to Our Sponsors

Content Includes

  • Science – The History of Ketamine
  • Clinical – Depression
  • Clinical – Psychedelic Effects
  • Development – Tech & Innovation
  • Clinical – Pain
  • Clinical – Psychotherapy and KAP
  • Industry – Ketamine Clinics
  • Nonprofit Presentations: Ketamine Fund & Mind Army

  • Industry – Capital & Markets
  • Clinical – PTSD
  • Clinical – Risks & Addiction Potential
  • Education – Training Services
  • Development – Pharmacology & NCEs
  • Science – Pharmacology
  • Industry – Communications

  • Science – The History of Ketamine
  • Clinical – Depression
  • Clinical – Psychedelic Effects
  • Development – Tech & Innovation
  • Clinical – Pain
  • Clinical – Psychotherapy and KAP
  • Industry – Ketamine Clinics
  • Nonprofit Presentations: Ketamine Fund & Mind Army
  • Industry – Capital & Markets
  • Clinical – PTSD
  • Clinical – Risks & Addiction Potential
  • Education – Training Services
  • Development – Pharmacology & NCEs
  • Science – Pharmacology
  • Industry – Communications


Add to Cart

Featured Speakers

  • Zappy Zapolin
  • Hamilton Morris
  • Jason Wallach, PhD
  • Lowan Stewart, MD FAAEM
  • Martha B. Koo, MD
  • Steven Mandel, MD
  • Samuel Ko, MD, MBA
  • Will Van Derveer, MD
  • Phil Wolfson, MD
  • Danielle Wise, PhD

  • David Feifel, MD, PHD
  • Jessica Katzman, PsyD
  • Kelan Thomas, PharmD
  • Robert Grant, MD
  • Sandhya Prashad, MD
  • Wes Ryan, MD
  • David Lodge, PhD
  • Itai Danovitch, MD, MBA
  • Brent Turnipseed, MD
  • +36 more

  • Zappy Zapolin
  • Hamilton Morris
  • Jason Wallach, PhD
  • Lowan Stewart, MD FAAEM
  • Martha B. Koo, MD
  • Steven Mandel, MD
  • Samuel Ko, MD, MBA
  • Will Van Derveer, MD
  • Phil Wolfson, MD
  • Danielle Wise, PhD
  • David Feifel, MD, PHD
  • Jessica Katzman, PsyD
  • Kelan Thomas, PharmD
  • Robert Grant, MD
  • Sandhya Prashad, MD
  • Wes Ryan, MD
  • David Lodge, PhD
  • Itai Danovitch, MD, MBA
  • Brent Turnipseed, MD
  • +36 more


Add to Cart

500+

Attendees

15

Panels

55

Speakers

14+

Hours of Footage

The Gold Standard in Psychedelic Investment

#PsyCap is a virtual psychedelic investment conference covering the top companies, the latest IPOs, the newest opportunities & the deepest insights.

Reviews

There are no reviews yet.

Be the first to review “The Ketamine Conference: A Molecular Masterclass”

TUNE INTO THE PSYCHEDELIC INSIDERS PODCAST
TUNE INTO THE PSYCHEDELIC INSIDERS PODCAST

JOIN THE DISCUSSION & GET EXCLUSIVE OFFERS
JOIN OUR SLACK CHANNEL
JOIN THE DISCUSSION & GET EXCLUSIVE OFFERS
JOIN OUR SLACK CHANNEL

Privacy Preference Center